Predicting Response to Capecitabine in Women With Metastatic Breast Cancer

NCT00953537 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

303

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: capecitabine
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

Centre Antoine Lacassagne